Human parathyroid peptide treatment of vertebral osteoporosis.

類似資料

• Treatment of osteoporosis with parathyroid peptide (hPTH 1-34) and oestrogen: increase in volumetric density of iliac cancellous bone may depend on reduced trabecular spacing as well as increased thickness of packets of newly formed bone.
  著者:: Bradbeer, J, 等
  出版事項: (1992)
• Temporal variations in iliac trabecular bone formation in vertebral osteoporosis.
  著者:: Arlot, M, 等
  出版事項: (1993)
• Periodic courses of human 1-34 parathyroid peptide alternating with calcitriol paradoxically reduce bone remodelling in spinal osteoporosis.
  著者:: Reeve, J, 等
  出版事項: (1987)
• A short-cycle ADFR regimen using parathyroid peptide hPTH 1–34 in idiopathic osteoporosis
  著者:: Reeve, J, 等
  出版事項: (1986)
• Iliac trabecular bone formation predicts radial trabecular bone density changes in type 1 osteoporosis.
  著者:: Hesp, R, 等
  出版事項: (1991)